Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merrilee Needham

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Frontiers in Immunology|April 17, 2023
Uncovering the significance of expanded CD8<sup>+</sup> large granular lymphocytes in inclusion body myositis: Insights into T cell phenotype and functional alterations, and disease severityEmily McLeish, Anuradha Sooda, Nataliya Slater, et al.
Journal of Neuroimmunology|September 27, 2012
Analysis of HLA-DRB3 alleles and supertypical genotypes in the MHC Class II region in sporadic inclusion body myositisArada Rojana-udomsart, Chalermchai Mitrpant, Ian James, et al.
Journal of Autoimmunity|December 3, 2023
High-resolution HLA genotyping in inclusion body myositis refines 8.1 ancestral haplotype association to DRB1*03:01:01 and highlights pathogenic role of arginine-74 of DRβ1 chainNataliya Slater, Anuradha Sooda, Emily McLeish, et al.
Journal of Neuroimmunology|May 29, 2012
High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: an analysis of disease-associated alleles and diplotypesArada Rojana-udomsart, Ian James, Alison Castley, et al.
European Journal of Neurology|October 30, 2024
Amyotrophic lateral sclerosis established as a multistep process across phenotypesLaura Ziser, Ruben P A van Eijk, Matthew C Kiernan, et al.
BMJ Open|October 4, 2016
Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohortPaul Talman, Thi Duong, Steve Vucic, et al.
Neuromuscular Disorders : NMD|September 2, 2009
Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotypeFrank L Mastaglia, Merrilee Needham, Adrian Scott, et al.
Clinical & Translational Immunology|October 3, 2022
Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double-blind, placebo-controlled, cross-over trialJerome D Coudert, Nataliya Slater, Anuradha Sooda, et al.
Plos One|June 18, 2024
Correction: Testosterone treatment combined with exercise to improve muscle strength, physical function and quality of life in men affected by inclusion body myositis: A randomised, double-blind, placebo-controlled, crossover trialSophia G Connor, Timothy J Fairchi, Yvonne C Learmonth, et al.
The Journal of Rheumatology|September 17, 2018
Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT StudyChristopher A Mecoli, Jin Kyun Park, Helene Alexanderson, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Frontiers in Immunology|April 17, 2023
Uncovering the significance of expanded CD8<sup>+</sup> large granular lymphocytes in inclusion body myositis: Insights into T cell phenotype and functional alterations, and disease severityEmily McLeish, Anuradha Sooda, Nataliya Slater, et al.
Journal of Neuroimmunology|September 27, 2012
Analysis of HLA-DRB3 alleles and supertypical genotypes in the MHC Class II region in sporadic inclusion body myositisArada Rojana-udomsart, Chalermchai Mitrpant, Ian James, et al.
Journal of Autoimmunity|December 3, 2023
High-resolution HLA genotyping in inclusion body myositis refines 8.1 ancestral haplotype association to DRB1*03:01:01 and highlights pathogenic role of arginine-74 of DRβ1 chainNataliya Slater, Anuradha Sooda, Emily McLeish, et al.
Journal of Neuroimmunology|May 29, 2012
High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: an analysis of disease-associated alleles and diplotypesArada Rojana-udomsart, Ian James, Alison Castley, et al.
European Journal of Neurology|October 30, 2024
Amyotrophic lateral sclerosis established as a multistep process across phenotypesLaura Ziser, Ruben P A van Eijk, Matthew C Kiernan, et al.
BMJ Open|October 4, 2016
Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohortPaul Talman, Thi Duong, Steve Vucic, et al.
Neuromuscular Disorders : NMD|September 2, 2009
Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotypeFrank L Mastaglia, Merrilee Needham, Adrian Scott, et al.
Clinical & Translational Immunology|October 3, 2022
Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double-blind, placebo-controlled, cross-over trialJerome D Coudert, Nataliya Slater, Anuradha Sooda, et al.
Plos One|June 18, 2024
Correction: Testosterone treatment combined with exercise to improve muscle strength, physical function and quality of life in men affected by inclusion body myositis: A randomised, double-blind, placebo-controlled, crossover trialSophia G Connor, Timothy J Fairchi, Yvonne C Learmonth, et al.
The Journal of Rheumatology|September 17, 2018
Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT StudyChristopher A Mecoli, Jin Kyun Park, Helene Alexanderson, et al.
Pageof 12